Prestige Consumer Healthcare, Inc. (PBH)
49.36
-0.35
(-0.70%)
USD |
NYSE |
Oct 20, 16:00
49.35
-0.01
(-0.02%)
Pre-Market: 07:09
Prestige Consumer Healthcare Gross Profit (TTM) : 569.98M for June 30, 2026
Gross Profit (TTM) Chart
Historical Gross Profit (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 569.98M |
| March 31, 2026 | 574.64M |
| December 31, 2025 | 598.72M |
| September 30, 2025 | 602.59M |
| June 30, 2025 | 608.00M |
| March 31, 2025 | 613.17M |
| December 31, 2024 | 594.36M |
| September 30, 2024 | 590.57M |
| June 30, 2024 | 593.10M |
| March 31, 2024 | 601.90M |
| December 31, 2023 | 603.52M |
| September 30, 2023 | 595.36M |
| June 30, 2023 | 595.65M |
| March 31, 2023 | 600.22M |
| December 31, 2022 | 594.63M |
| September 30, 2022 | 599.31M |
| June 30, 2022 | 596.20M |
| March 31, 2022 | 595.78M |
| December 31, 2021 | 584.78M |
| September 30, 2021 | 568.89M |
| June 30, 2021 | 548.98M |
| March 31, 2021 | 523.53M |
| December 31, 2020 | 530.02M |
| September 30, 2020 | 528.37M |
| June 30, 2020 | 527.27M |
| Date | Value |
|---|---|
| March 31, 2020 | 527.46M |
| December 31, 2019 | 521.54M |
| September 30, 2019 | 522.80M |
| June 30, 2019 | 522.98M |
| March 31, 2019 | 528.53M |
| December 31, 2018 | 531.10M |
| September 30, 2018 | 539.11M |
| June 30, 2018 | 545.31M |
| March 31, 2018 | 548.08M |
| December 31, 2017 | 537.30M |
| September 30, 2017 | 515.45M |
| June 30, 2017 | 496.48M |
| March 31, 2017 | 474.94M |
| December 31, 2016 | 463.46M |
| September 30, 2016 | 455.47M |
| June 30, 2016 | 451.78M |
| March 31, 2016 | 443.54M |
| December 31, 2015 | 435.78M |
| September 30, 2015 | 431.66M |
| June 30, 2015 | 416.09M |
| March 31, 2015 | 388.48M |
| December 31, 2014 | 360.95M |
| September 30, 2014 | 332.52M |
| June 30, 2014 | 325.26M |
| March 31, 2014 | 326.56M |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (TTM) Benchmarks
| Supernus Pharmaceuticals, Inc. | 629.69M |
| Phibro Animal Health Corp. | 510.18M |
| Structure Therapeutics, Inc. | -4.876M |
| ANI Pharmaceuticals, Inc. | 505.18M |
| Corcept Therapeutics, Inc. | 816.73M |